UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041608
Receipt number R000047289
Scientific Title A prospective observational study of the effect of kidney senescence on the prognosis of allograft in living kidney transplantation
Date of disclosure of the study information 2020/08/30
Last modified on 2020/08/30 16:46:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective observational study of the effect of kidney senescence on the prognosis of allograft in living kidney transplantation

Acronym

A study of the effect of kidney senescence on the prognosis of allograft

Scientific Title

A prospective observational study of the effect of kidney senescence on the prognosis of allograft in living kidney transplantation

Scientific Title:Acronym

A study of the effect of kidney senescence on the prognosis of allograft

Region

Japan


Condition

Condition

renal transplant recipients

Classification by specialty

Nephrology Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To test the hypothesis that senescence of the allograft is a determining factor for calcineurin inhibitor-induced nephrotoxicity

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Effect of allograft senescence on the incidence of CNI nephrotoxicity

Key secondary outcomes

1) Effect of allograft senescence on the decline rate in allograft function
2) Effect of progression in allograft senescence on the incidence of CNI nephrotoxicity
3) Effect of progression in allograft senescence on the decline rate in allograft function
4) Exploration of clinical factors contributing to allograft senescence and progression in allograft senescence
5) The detective rate of incidence in allograft senescence and CNI Nephrotoxicity by serum soluble alpha Klotho
6) Co-staining rate with P16 and alpha Klotho in the tubules
7) Exploring the accuracy of detecting allograft senescence by urine cytology.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Donor/recipient for living donor kidney transplantation or recipient for allograft biopsy

Key exclusion criteria

recipients with cadaver donor kidney and those with simultaneous pancreas and kidney transplantation

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Tadashi
Middle name
Last name SOFUE

Organization

Kagawa University Hospital

Division name

Department of Nephrology

Zip code

761-0793

Address

1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, Japan

TEL

087-891-2150

Email

sofue@med.kagawa-u.ac.jp


Public contact

Name of contact person

1st name Tadashi
Middle name
Last name SOFUE

Organization

Kagawa University Hospital

Division name

Department of Nephrology

Zip code

7610793

Address

1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, Japan

TEL

087-891-2150

Homepage URL


Email

sofue@med.kagawa-u.ac.jp


Sponsor or person

Institute

Kagawa University Hospital

Institute

Department

Personal name



Funding Source

Organization

Kagawa University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kagawa University

Address

1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, Japan

Tel

0878912150

Email

chiken-b.@med.kagawa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 08 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 06 Month 17 Day

Date of IRB


Anticipated trial start date

2020 Year 09 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

evaluation item
Patient background: patient ID, date of birth, gender, BMI, medical history, and current medical history.
(2) Donor kidney function: Cr, eGFR, and change in eGFR per year
3) General blood tests: TP, Alb, BUN, UA, Na, K, LDH, CPK, CRP, WBC, RBC, Hb, Plt, fasting blood glucose, HbA1c, and other general biochemical tests
4) General urinalysis: urine protein, urine albumin, urine NAG, urine beta2-microglobulin, urine sedimentation rate
(5) Vital signs: blood pressure (home blood pressure), pulse rate, and presence/absence of medication.
(6) Special blood tests: serum complement level, serum globulin level, serum soluble alpha Klotho
(vii) Special urine test: urinary angiotensinogen, urinary soluble alpha Klotho
(h) Urine cytology: Number of P16-positive cells in urine
(ix) Donor renal histology assessment: presence of fibrous intimal thickening in the interlobar artery, intimal thickening area, glomerular sclerosis rate, interstitial fibrosis rate, immunostaining (e.g. IgA), electron microscopy, number of glomeruli per unit area
10 Donated renal tissue special stains: p16-positive cells and alphaKlotho-positive cells


Management information

Registered date

2020 Year 08 Month 30 Day

Last modified on

2020 Year 08 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047289


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name